article thumbnail

Micro-robots, smart toilets, and 3D bioprinted organs: the future of healthcare

Pharmaceutical Technology

It is the year 2030. You have just received the results from your whole genome sequencing test, offered through your public health provider, and discovered that you have a 75% chance of developing a rare form of cancer. With the personalised medicine market reaching $93bn by 2030, there will be a range of treatments available.

article thumbnail

Value-Based Care: How Payers Can Empower Providers to Deliver Better Outcomes

Clarify Health

The Centers for Medicare and Medicaid Services (CMS) has been at the forefront of value-based care , aiming to move every Medicare fee-for-service beneficiary and most Medicaid beneficiaries to care relationships with accountability for quality and total cost of care by 2030.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sorry, the Inflation Bill won’t lower healthcare costs

World of DTC Marketing

Congress has taken decisive action to reduce drug prices while ignoring that overall healthcare spending will be a substantial part of GNP. 1ne: A new analysis predicts that by 2030, 48.9% Healthcare providers also receive part of these administrative costs for notetaking and record-keeping during medical billing.

article thumbnail

Is Medical Sales Still A Lucrative Job?

Contrarian Sales Techniques

According to the Bureau of Labor Statistics, employment of medical and pharmaceutical sales representatives is projected to grow 3 percent from 2020 to 2030, about as fast as the average for all occupations. Be prepared for rejection : Medical sales is a competitive industry, and you may face rejection from companies or healthcare providers.

article thumbnail

George taps Medisante tech for decentralised blood pressure trial

pharmaphorum

The alliance is another example of the shift by the pharma industry towards decentralised clinical trials (DCTs), which use technology to communicate with participants and collect data, via telemedicine and mobile/local healthcare providers, often with the help of wearable devices and sensors.

article thumbnail

FDA starts review of Sanofi, AZ antibody for RSV prevention

pharmaphorum

Despite the RSV vaccine threat, analysts at GlobalData have predicted that nirsevimab could reach $3 billion in annual revenue by 2030, assuming a launch in both Europe and the US this year.

FDA 52
article thumbnail

12 Strategies to Increase Patient Engagement in Healthcare

LEVO Health

Fragmented Care: A lack of coordination across healthcare providers can make navigating the system challenging for patients. Time Constraints and Accessibility: Busy schedules and limited healthcare access hinder patient engagement. Portals can also facilitate secure messaging with healthcare providers.